Efficacy and safety of vismodegib in advanced basal-cell carcinoma

New England Journal of Medicine

Volumn 366, Issue 23, 2012, Pages 2171-2179

  Sekulic, Aleksandar ^a   Migden, Michael R ^b   Oro, Anthony E ^c   Dirix, Luc ^d   Lewis, Karl D ^e   Hainsworth, John D ^f   Solomon, James A ^g   Yoo, Simon ^h   Arron, Sarah T ⁱ   Friedlander, Philip A ^j,k   Marmur, Ellen ^k   Rudin, Charles M ^l   Chang, Anne Lynn S ^c   Low, Jennifer A ^m   Mackey, Howard M ^m   Yauch, Robert L ^m   Graham, Richard A ^m   Reddy, Josina C ^m   Hauschild, Axel ⁿ  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SINT AUGUSTINUS HOSPITAL   (Belgium)

^e UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^f SARAH CANNON RESEARCH INSTITUTE   (United States)

^g Ameriderm Research   (United States)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j DANA FARBER CANCER INSTITUTE   (United States)

^k MOUNT SINAI MEDICAL CENTER   (United States)

^l JOHNS HOPKINS UNIVERSITY   (United States)

^m GENENTECH INC   (United States)

ⁿ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VISMODEGIB;

ADULT; AGED; ALOPECIA; ANOREXIA; ARTICLE; BASAL CELL CARCINOMA; BRAIN ISCHEMIA; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG WITHDRAWAL; DYSGEUSIA; FATIGUE; FEMALE; HEART INFARCTION; HUMAN; HUMAN TISSUE; HYPOVOLEMIC SHOCK; MALE; MENINGISM; METASTASIS POTENTIAL; MULTICENTER STUDY; MUSCLE SPASM; NAUSEA; OVERALL SURVIVAL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT REDUCTION;

EID: 84861856844     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1113713     Document Type: Article

References (14)

1. Rogers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010;146:283-7.
2. Gailani MR, Ståhle-Bäckdahl M, Leffell DJ, et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat Genet 1996; 14:78-81. (Pubitemid 26301550)
3. Aszterbaum M, Rothman A, Johnson RL, et al. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol 1998;110:885-8. (Pubitemid 28237693)
4. Von Hoff DD, LoRusso PM, Rudin CM, et al. Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N Engl J Med 2009;361:1164-72.
5. LoRusso PM, Rudin CM, Reddy JC, et al. Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin Cancer Res 2011; 17:2502-11.
6. Graham RA, Lum BL, Cheeti S, et al. Pharmacokinetics of hedgehog pathway inhibitor GDC-0449 in patients with refractory or untreatable locally advanced or metastatic solid tumors: the role of alpha 1-acid glycoprotein binding. Clin Cancer Res 2011;17:2512-20.
7. Therasse P, Arbuck SG, Eisenhauser EA, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000;92:205-16. (Pubitemid 30099779)
8. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55. (Pubitemid 13149996)
9. Bonifas JM, Pennypacker S, Chuang PT, et al. Activation of expression of hedgehog target genes in basal cell carcinomas. J Invest Dermatol 2001;116:739-42. (Pubitemid 32467653)
10. St-Jacques B, Dassule HR, Karavanova I, et al. Sonic hedgehog signaling is essential for hair development. Curr Biol 1998; 8:1058-68. (Pubitemid 28451030)
11. Chiang C, Swan RZ, Grachtchouk M, et al. Essential role for sonic hedgehog during hair follicle morphogenesis. Dev Biol 1999;205:1-9. (Pubitemid 29042654)
12. Hall JM, Bell ML, Finger TE. Disruption of sonic hedgehog signaling alters growth and patterning of lingual taste papillae. Dev Biol 2003;255:263-77. (Pubitemid 36331948)
13. Liu H-X, MacCallum DK, Edwards C, Gaffield W, Mistretta CM. Sonic hedgehog exerts distinct, stage-specific effects on tongue and taste papilla development. Dev Biol 2004;276:280-300. (Pubitemid 39592394)
14. Tang JY, Mackay-Wiggan JM, Aszterbaum M, et al. Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome. N Engl J Med 2012;366: 2180-8.